Effects of Two Weight-Loss Medications, Liraglutide and Orlistat, on Liver Enzymes in Patients with Overweight or Obesity in a Real-World Setting

被引：1
|
作者：
Gorgojo-Martinez, Juan J.
Chicharro, Pablo L. Lois
Ferreira-Ocampo, Pablo J.
Doejo-Marciales, Sandra C.
Barra-Malig, Solange F.
Almodovar-Ruiz, Francisca
机构：
来源：
DIABETES | 2022年 / 71卷
关键词：
D O I：
10.2337/db22-1440-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1440-P
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Effectiveness and tolerability of orlistat and liraglutide in patients with obesity in a real-world setting: The XENSOR Study
    Gorgojo-Martinez, Juan J.
    Basagoiti-Carreno, Belen
    Sanz-Velasco, Alberto
    Serrano-Moreno, Clara
    Almodovar-Ruiz, Francisca
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2019, 73 (11)
  • [2] Real-World Assessment of Orlistat and Liraglutide in Patients with Obesity: The XENSOR Study
    Gorgojo-Martinez, Juan J.
    Belen, Basagoiti-Carreno
    Sanz-Velasco, Alberto
    Serrano-Moreno, Clara
    Francisca, Almodovar-Ruiz
    DIABETES, 2019, 68
  • [3] Effectiveness and persistence of anti-obesity medications (liraglutide 3 mg, lorcaserin, and orlistat) in a real-world primary care setting
    Leventhal-Perek, Sharon
    Shani, Michal
    Schonmann, Yochai
    FAMILY PRACTICE, 2023, 40 (5-6) : 629 - 637
  • [4] Weight loss response in patients with obesity treated with injectable semaglutide in a real-world setting
    Khaled Alabduljabbar
    Moath Alsaqaaby
    Karl J. Neff
    Michael Crotty
    Carel W. le Roux
    Endocrine, 2024, 83 : 392 - 398
  • [5] Weight loss response in patients with obesity treated with injectable semaglutide in a real-world setting
    Alabduljabbar, Khaled
    Alsaqaaby, Moath
    Neff, Karl J.
    Crotty, Michael
    le Roux, Carel W.
    ENDOCRINE, 2024, 83 (02) : 392 - 398
  • [6] Real-world effectiveness of Semaglutide treatment on weight loss maintenance after weight loss in patients with obesity or overweight and diabetes
    Del Prete, Michela
    Gavazzi, Lidia
    Disoteo, Olga Eugenia
    Vignati, Federico
    Di Sacco, Gianleone
    Muratori, Fabrizio
    EATING AND WEIGHT DISORDERS-STUDIES ON ANOREXIA BULIMIA AND OBESITY, 2025, 30 (01)
  • [7] Weight-Loss Interventions in Patients with Overweight/Obesity and CKD
    Chang, Ryan
    Frost, Livia Ann
    Navaneethan, Sankar D.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [8] Real-world weight loss with diabetes medications: But is it actually real?
    Elmes, Abigail T.
    Jarrett, Jennie B.
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2022, 62 (01) : 27 - 27
  • [9] Real-world effectiveness of tirzepatide versus semaglutide for weight loss in overweight or obese patients in an ambulatory care setting
    Trinh, Huong
    Donovan, Anthony
    McAdam-Marx, Carrie
    DIABETES OBESITY & METABOLISM, 2025,
  • [10] Liraglutide 3 mg for Weight Loss in a Real-World Setting: Clinical Outcomes after 56 Weeks
    Buckley, Adam J.
    Suliman, Mohamed
    Al Tikriti, Alia
    Lessan, Nader
    Le Roux, Carel
    Tan, Tricia M.
    Barakat, Maha T.
    DIABETES, 2019, 68
12345